Intellicheck Mobilisa, Inc. (IDN) Intellicheck Mobilisa: Analysts Have Strong Sell Ratings Intellicheck Mobilisa, Inc. (IDN) shares are holding over their moving midpoints, showing a postitive uptrend for Technology organization. So as to tell which way […]
Identiv, Inc. (INVE) Identiv Is Moving in the Right Direction Identiv, Inc. (INVE) is the leading global player in physical security and secure identification. Identiv’s products, software, systems, and services address the markets for physical […]
Eltek Ltd. (NASDAQELTK) Lower Margins Could Impact Eltek Performance Eltek Ltd. (NASDAQ:ELTK) is a printed circuit board manufacturer (PCB) headquartered in Israel. ELTK has been around for more than 40 years and serves customers in […]
Forward Industries, Inc. (FORD) Keep An Eye on Forward Industries Forward Industries, Inc. (FORD) an architect and wholesaler of custom convey and defensive arrangements. Merchants are investigating how shares of Forward Industries Inc. (Portage) have […]
Digital Turbine, Inc. (NASDAQAPPS) A look at Analysts Expectations About Digital Turbine Experts are anticipating that Digital Turbine, Inc. (NASDAQ:APPS) is going to report a profit of $-0.08 for every share. The real income for […]
Verastem Inc. (VSTM:NASDAQ) Verastem Inc. (VSTM:NASDAQ) has a market cap of $80M. A Biotech Watchlist veteran, Verastem is attempting to lift itself up in the wake of the significant Phase 2 COMMAND trial disappointment. New […]
Penny stock investing can often be a highly rewarding experience, considering the fact that these stocks can often generate oversized returns. That being said, these stocks are volatile in nature, and hence, it is advisable […]
Over the course of the past weeks, Novavax, Inc. (NASDAQ:NVAX) has gathered a lot of attention, and the data from Google Trends confirms that as well. In addition to that, the trading volumes in the […]
Wave Life Sciences (NASDAQ:WVE) Wave Life Sciences (NASDAQ:WVE) stock price have been on a tear, up just about 200% from their $9 base in the primary quarter. Bio speculators have been astounded that a preclinical […]
Tokai Pharmaceuticals’ (NASDAQ:TKAI) The business case for Tokai Pharmaceuticals’ (NASDAQ:TKAI) lead prostate malignancy venture, galeterone, was flawed well before late 70% breakdown in the gathering’s share price. Also, the issues were more basic even than […]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes